This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

GABA and Beta-cell Regeneration

Sponsored by Ministry of Health and Population, Egypt

About this trial

Last updated 5 years ago

Study ID

icel

Status

Completed

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
18 to 25 Years
All
All

Trial Timing

Ended 5 years ago

What is this trial about?

GABA(gamma-Aminobutyric acid) may be used for decreasing anti-gad antibodies and leads beta-cell regeneration.

What are the participation requirements?

Yes

Inclusion Criteria

- type 1 diabetes patients age from 18 to 25 years on basal bolus insulin

No

Exclusion Criteria

thyroid problems liver disease kidney disease

Locations

Location

Status